5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: a genetic susceptibility mechanism for depression

1.5k indexed citations

Abstract

loading...

About

This paper, published in 2005, received 1.5k indexed citations. Written by Lukas Pezawas, Andreas Meyer‐Lindenberg, Emily M. Drabant, Beth A. Verchinski, Karen E. Muñoz, Bhaskar Kolachana, Michael Egan, Venkata S. Mattay, Ahmad R. Hariri and Daniel R. Weinberger covering the research area of Clinical Psychology, Experimental and Cognitive Psychology and Psychiatry and Mental health. It is primarily cited by scholars working on Cognitive Neuroscience (689 citations), Experimental and Cognitive Psychology (456 citations) and Cellular and Molecular Neuroscience (369 citations). Published in Nature Neuroscience.

In The Last Decade

doi.org/10.1038/nn1463 →

Countries where authors are citing 5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: a genetic susceptibility mechanism for depression

Specialization
Citations

This map shows the geographic impact of 5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: a genetic susceptibility mechanism for depression. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by 5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: a genetic susceptibility mechanism for depression with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites 5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: a genetic susceptibility mechanism for depression more than expected).

Fields of papers citing 5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: a genetic susceptibility mechanism for depression

Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of 5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: a genetic susceptibility mechanism for depression. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the 5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: a genetic susceptibility mechanism for depression.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

This paper is also available at doi.org/10.1038/nn1463.

Explore hit-papers with similar magnitude of impact

Breakdown of academic impact, for the paper Maintenance Olaparib for Germline BRCA -Mutated Metastatic Pancreatic Cancer Breakdown of academic impact, for the paper Early indicators of prognosis in fulminant hepatic failure Breakdown of academic impact, for the paper Cognitive impairment in depression: a systematic review and meta-analysis Breakdown of academic impact, for the paper Association between insulin resistance and the development of cardiovascular disease Breakdown of academic impact, for the paper The burden of disease in older people and implications for health policy and practice Breakdown of academic impact, for the paper Metodologi Penelitian Kualitatif Breakdown of academic impact, for the paper Limits on lithospheric stress imposed by laboratory experiments Breakdown of academic impact, for the paper Mild Cognitive Impairment Represents Early-Stage Alzheimer Disease Breakdown of academic impact, for the paper Vaccine hesitancy Breakdown of academic impact, for the paper National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment
Rankless by CCL
2026